Mereo BioPharma Group plc (MREO) Misses Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts MREO Hot Sheet
Price: $0.35 -7.89%
Financial Fact:
Gross profit (loss): 21.36K
Today's EPS Names:
HOVR, VFS, PGR, More
Financial Fact:
Gross profit (loss): 21.36K
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Mereo BioPharma Group plc (NASDAQ: MREO) reported Q2 EPS of ($0.02), $0.01 worse than the analyst estimate of ($0.01).
For earnings history and earnings-related data on Mereo BioPharma Group plc (MREO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- Cavitation Technologies signs $42M tender offer deal with BrightFlixx
- McGraw Hill completes refinancing, makes $50M debt prepayment
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
